353 related articles for article (PubMed ID: 12856249)
1. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity.
von Lindern JJ; Niederhagen B; Bergé S; Appel T
J Oral Maxillofac Surg; 2003 Jul; 61(7):774-8. PubMed ID: 12856249
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
[TBL] [Abstract][Full Text] [Related]
3. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
Sidebottom AJ; Patel AA; Amin J
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
[TBL] [Abstract][Full Text] [Related]
4. The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.
Pihut M; Ferendiuk E; Szewczyk M; Kasprzyk K; Wieckiewicz M
J Headache Pain; 2016; 17():29. PubMed ID: 27011213
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
Ihde SK; Konstantinovic VS
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin and Percutaneous Needle Electrolysis for the Treatment of Chronic Masticatory Myalgia.
Gonzalez-Perez LM; Vera-Martin R; Montes-Latorre E; Torres-Carranza E; Infante-Cossio P
Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104216
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial.
Abbott JA; Jarvis SK; Lyons SD; Thomson A; Vancaille TG
Obstet Gynecol; 2006 Oct; 108(4):915-23. PubMed ID: 17012454
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study.
Freund BJ; Schwartz M
Headache; 2000 Mar; 40(3):231-6. PubMed ID: 10759926
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
[TBL] [Abstract][Full Text] [Related]
10. Improvement in pelvic pain with botulinum toxin type A - Single vs. repeat injections.
Nesbitt-Hawes EM; Won H; Jarvis SK; Lyons SD; Vancaillie TG; Abbott JA
Toxicon; 2013 Mar; 63():83-7. PubMed ID: 23220489
[TBL] [Abstract][Full Text] [Related]
11. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
12. Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.
Marciniak CM; Harvey RL; Gagnon CM; Duraski SA; Denby FA; McCarty S; Bravi LA; Polo KM; Fierstein KM
Am J Phys Med Rehabil; 2012 Dec; 91(12):1007-19. PubMed ID: 23064478
[TBL] [Abstract][Full Text] [Related]
13. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
[TBL] [Abstract][Full Text] [Related]
14. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
Fallah HM; Currimbhoy S
J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
[No Abstract] [Full Text] [Related]
15. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
Song PC; Schwartz J; Blitzer A
Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of botulinum toxin type A for the treatment of chronic masticatory myofascial pain: A case series.
Baker JS; Nolan PJ
J Am Dent Assoc; 2017 Jan; 148(1):33-39. PubMed ID: 28314397
[TBL] [Abstract][Full Text] [Related]
18. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
von Lindern JJ
Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
[TBL] [Abstract][Full Text] [Related]
19. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
Laskin DM
Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study.
Khawaja SN; Scrivani SJ; Holland N; Keith DA
J Oral Maxillofac Surg; 2017 Nov; 75(11):2307-2315. PubMed ID: 29078865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
